285 related articles for article (PubMed ID: 22542539)
1. Prolonged survival and milder impairment of motor function in the SOD1 ALS mouse model devoid of fibroblast growth factor 2.
Thau N; Jungnickel J; Knippenberg S; Ratzka A; Dengler R; Petri S; Grothe C
Neurobiol Dis; 2012 Aug; 47(2):248-57. PubMed ID: 22542539
[TBL] [Abstract][Full Text] [Related]
2. Characterizing the multiple roles of FGF-2 in SOD1
Kefalakes E; Böselt S; Sarikidi A; Ettcheto M; Bursch F; Naujock M; Stanslowsky N; Schmuck M; Barenys M; Wegner F; Grothe C; Petri S
J Cell Physiol; 2019 May; 234(5):7395-7410. PubMed ID: 30370540
[TBL] [Abstract][Full Text] [Related]
3. Isoform-selective as opposed to complete depletion of fibroblast growth factor 2 (FGF-2) has no major impact on survival and gene expression in SOD1
Kefalakes E; Sarikidi A; Bursch F; Ettcheto M; Schmuck M; Rumpel R; Grothe C; Petri S
Eur J Neurosci; 2019 Sep; 50(6):3028-3045. PubMed ID: 30883949
[TBL] [Abstract][Full Text] [Related]
4. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of Abeta is associated with acceleration of onset of motor impairment and superoxide dismutase 1 aggregation in an amyotrophic lateral sclerosis mouse model.
Li QX; Mok SS; Laughton KM; McLean CA; Volitakis I; Cherny RA; Cheung NS; White AR; Masters CL
Aging Cell; 2006 Apr; 5(2):153-65. PubMed ID: 16626394
[TBL] [Abstract][Full Text] [Related]
6. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
[TBL] [Abstract][Full Text] [Related]
7. Over-expression of Hsp27 does not influence disease in the mutant SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Krishnan J; Vannuvel K; Andries M; Waelkens E; Robberecht W; Van Den Bosch L
J Neurochem; 2008 Sep; 106(5):2170-83. PubMed ID: 18624915
[TBL] [Abstract][Full Text] [Related]
8. Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS.
Li W; Brakefield D; Pan Y; Hunter D; Myckatyn TM; Parsadanian A
Exp Neurol; 2007 Feb; 203(2):457-71. PubMed ID: 17034790
[TBL] [Abstract][Full Text] [Related]
9. Trehalose decreases mutant SOD1 expression and alleviates motor deficiency in early but not end-stage amyotrophic lateral sclerosis in a SOD1-G93A mouse model.
Li Y; Guo Y; Wang X; Yu X; Duan W; Hong K; Wang J; Han H; Li C
Neuroscience; 2015 Jul; 298():12-25. PubMed ID: 25841320
[TBL] [Abstract][Full Text] [Related]
10. Systemic treatment with adipose-derived mesenchymal stem cells ameliorates clinical and pathological features in the amyotrophic lateral sclerosis murine model.
Marconi S; Bonaconsa M; Scambi I; Squintani GM; Rui W; Turano E; Ungaro D; D'Agostino S; Barbieri F; Angiari S; Farinazzo A; Constantin G; Del Carro U; Bonetti B; Mariotti R
Neuroscience; 2013 Sep; 248():333-43. PubMed ID: 23727509
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of metallothionein-I, a copper-regulating protein, attenuates intracellular copper dyshomeostasis and extends lifespan in a mouse model of amyotrophic lateral sclerosis caused by mutant superoxide dismutase-1.
Tokuda E; Okawa E; Watanabe S; Ono S
Hum Mol Genet; 2014 Mar; 23(5):1271-85. PubMed ID: 24163136
[TBL] [Abstract][Full Text] [Related]
12. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M
Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic immunization with a glatiramer acetate derivative does not alter survival in G93A and G37R SOD1 mouse models of familial ALS.
Haenggeli C; Julien JP; Mosley RL; Perez N; Dhar A; Gendelman HE; Rothstein JD
Neurobiol Dis; 2007 Apr; 26(1):146-52. PubMed ID: 17276077
[TBL] [Abstract][Full Text] [Related]
14. Granulocyte-colony stimulating factor improves outcome in a mouse model of amyotrophic lateral sclerosis.
Pitzer C; Krüger C; Plaas C; Kirsch F; Dittgen T; Müller R; Laage R; Kastner S; Suess S; Spoelgen R; Henriques A; Ehrenreich H; Schäbitz WR; Bach A; Schneider A
Brain; 2008 Dec; 131(Pt 12):3335-47. PubMed ID: 18835867
[TBL] [Abstract][Full Text] [Related]
15. Effect of thymic stimulation of CD4+ T cell expansion on disease onset and progression in mutant SOD1 mice.
Sheean RK; Weston RH; Perera ND; D'Amico A; Nutt SL; Turner BJ
J Neuroinflammation; 2015 Feb; 12():40. PubMed ID: 25889790
[TBL] [Abstract][Full Text] [Related]
16. Galectin-1 deficiency improves axonal swelling of motor neurones in SOD1(G93A) transgenic mice.
Kobayakawa Y; Sakumi K; Kajitani K; Kadoya T; Horie H; Kira J; Nakabeppu Y
Neuropathol Appl Neurobiol; 2015 Feb; 41(2):227-44. PubMed ID: 24707896
[TBL] [Abstract][Full Text] [Related]
17. The accumulation of enzymatically inactive cuproenzymes is a CNS-specific phenomenon of the SOD1
Hilton JB; Kysenius K; White AR; Crouch PJ
Exp Neurol; 2018 Sep; 307():118-128. PubMed ID: 29906423
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of intracellular copper homeostasis is common to transgenic mice expressing human mutant superoxide dismutase-1s regardless of their copper-binding abilities.
Tokuda E; Okawa E; Watanabe S; Ono S; Marklund SL
Neurobiol Dis; 2013 Jun; 54():308-19. PubMed ID: 23321002
[TBL] [Abstract][Full Text] [Related]
19. Different human copper-zinc superoxide dismutase mutants, SOD1G93A and SOD1H46R, exert distinct harmful effects on gross phenotype in mice.
Pan L; Yoshii Y; Otomo A; Ogawa H; Iwasaki Y; Shang HF; Hadano S
PLoS One; 2012; 7(3):e33409. PubMed ID: 22438926
[TBL] [Abstract][Full Text] [Related]
20. Loss of glial fibrillary acidic protein marginally accelerates disease progression in a SOD1(H46R) transgenic mouse model of ALS.
Yoshii Y; Otomo A; Pan L; Ohtsuka M; Hadano S
Neurosci Res; 2011 Jul; 70(3):321-9. PubMed ID: 21453731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
